Investor Presentaiton slide image

Investor Presentaiton

U.S. Other listed peers peers Eurofins Pharma Services in more detail Spanning the entire drug development cycle eurofins Genomics Sequencing Oligonucleotides Pharmacogenomics Transcriptomics Genotyping SNP-analysis IDT/Danaher, Genewiz/Brooks Discovery Pharmacology High-throughput- screening Molecular- Pharmacology Cell-based Assays In Vitro Screening In Vitro Profiling In Vivo Safety In Vivo efficacy Charles River Pre-clinical/ Early Development Pharmacology Bioanalytical Analysis Translational Medicine Phase I Studies Catalent, Charles River, ICON, IQVIA, LabCorp, Syneos Health, PPD Clinical (Central Laboratory/ Bioanalytical) Biomarkers Bioanalysis Immunogenicity Proteomics Microbiological and Anti- infective analysis Bioavailability Bioequivalence Charles River, ICON, IQVIA, LabCorp, Quest, Syneos Health, PPD Development & Manufacturing (CDMO) Complex API Development Multi-Step Synthesis Cytotoxic and Highly Potent DS and DP Manufacturing Catalent, Charles River BioPharma Products Testing Pharmaceuticals, Biologics, Medical Device: Safety, Characterization, Quality Control, Process Development Hygiene Monitoring Packaging Charles River, PPD Abcam, etc. Evotec, Abcam, Albany Molecular Research, etc. Evotec, Parexel, etc. Albany Molecular Research, etc. Albany Molecular Research, Lonza, Cambrex etc. SGS, Wu Xi App Tec, etc. 32 32
View entire presentation